{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:03:49Z","timestamp":1789578229880,"version":"build-2803163510"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/bor.0000000000000222","type":"journal-article","created":{"date-parts":[[2015,9,10]],"date-time":"2015-09-10T11:21:01Z","timestamp":1441884061000},"page":"563-570","source":"Crossref","is-referenced-by-count":82,"title":["Cancer and scleroderma"],"prefix":"10.1097","volume":"27","author":[{"given":"Ami A.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Casciola-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.1780360405","article-title":"Cancer in systemic sclerosis.","volume":"36","author":"Abu-Shakra","year":"1993","journal-title":"Arthritis Rheumat"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/kes303","article-title":"Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies.","volume":"52","author":"Bonifazi","year":"2013","journal-title":"Rheumatology"},{"key":"R3-8-20210128","first-page":"1113","article-title":"A cohort study of cancer incidence in systemic sclerosis.","volume":"33","author":"Derk","year":"2006","journal-title":"J Rheumatol"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.62.8.728","article-title":"Risk of cancer in patients with scleroderma: a population based cohort study.","volume":"62","author":"Hill","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R5-8-20210128","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009742.2011.618145","article-title":"Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan.","volume":"41","author":"Kuo","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2133.2010.09861.x","article-title":"Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study.","volume":"163","author":"Olesen","year":"2010","journal-title":"Br J Dermatol"},{"key":"R7-8-20210128","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/art.37969","article-title":"Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.","volume":"65","author":"Onishi","year":"2013","journal-title":"Arthritis Rheumat"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T","article-title":"Incidence of cancer among patients with systemic sclerosis.","volume":"76","author":"Rosenthal","year":"1995","journal-title":"Cancer"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00296-009-1348-y","article-title":"Malignancy in scleroderma patients from south west England: a population-based cohort study.","volume":"31","author":"Siau","year":"2011","journal-title":"Rheumatol Int"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.canep.2013.04.014","article-title":"The risk of cancer development in systemic sclerosis: a meta-analysis.","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/28.1.65","article-title":"Carcinoma of breast and scleroderma: four further cases and a literature review.","volume":"28","author":"Forbes","year":"1989","journal-title":"Br J Rheumatol"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s10067-004-0940-5","article-title":"Association between systemic sclerosis and breast cancer: eight new cases and review of the literature.","volume":"23","author":"Launay","year":"2004","journal-title":"Clin Rheumatol"},{"key":"R13-8-20210128","first-page":"637","article-title":"Increased incidence of carcinoma of the tongue in patients with systemic sclerosis.","volume":"32","author":"Derk","year":"2005","journal-title":"J Rheumatol"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/03009740802642062","article-title":"Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre.","volume":"38","author":"Kang","year":"2009","journal-title":"Scand J Rheumat"},{"key":"R15-8-20210128","first-page":"1136","article-title":"Incidence of lung cancer in systemic sclerosis.","volume":"12","author":"Peters-Golden","year":"1985","journal-title":"J Rheumatol"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/art.39022","article-title":"Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0b013e32834a5081","article-title":"Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.","volume":"23","author":"Shah","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/art.21261","article-title":"Prevalence of Barretts esophagus in systemic sclerosis.","volume":"52","author":"Wipff","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/hep.23095","article-title":"Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers.","volume":"50","author":"Cavazza","year":"2009","journal-title":"Hepatology"},{"key":"R22-8-20210128","first-page":"100","article-title":"Malignancies in Wegeners granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.","volume":"35","author":"Faurschou","year":"2008","journal-title":"J Rheumatol"},{"key":"R23-8-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.25061","article-title":"Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.","volume":"62","author":"Monach","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R24-8-20210128","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.transproceed.2008.12.013","article-title":"Significant risk factors for occurrence of cancer after renal transplantation: a single center cohort study of 1265 cases.","volume":"41","author":"Bichari","year":"2009","journal-title":"Transplant Proc"},{"key":"R25-8-20210128","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archdermatol.2009.276","article-title":"Incidence of and risk factors for skin cancer after heart transplant.","volume":"145","author":"Brewer","year":"2009","journal-title":"Arch Dermatol"},{"key":"R26-8-20210128","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/j.transproceed.2010.08.002","article-title":"Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.","volume":"42","author":"Marcen","year":"2010","journal-title":"Transplant Proc"},{"key":"R27-8-20210128","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/j.1600-6143.2005.01125.x","article-title":"Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil.","volume":"5","author":"Robson","year":"2005","journal-title":"Am J Transplant"},{"key":"R28-8-20210128","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/0959-8049(95)00460-2","article-title":"Secondary Raynauds phenomenon and other late vascular complications following chemotherapy for testicular cancer.","volume":"31A","author":"Berger","year":"1995","journal-title":"Eur J Cancer"},{"key":"R30-8-20210128","first-page":"1341","article-title":"Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis.","volume":"30","author":"Clowse","year":"2003","journal-title":"J Rheumatol"},{"key":"R31-8-20210128","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archderm.1973.01620190029007","article-title":"Cutaneous toxicity of bleomycin therapy.","volume":"107","author":"Cohen","year":"1973","journal-title":"Arch Dermatol"},{"key":"R32-8-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10067-002-0635-8","article-title":"Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer.","volume":"22","author":"De Angelis","year":"2003","journal-title":"Clin Rheumatol"},{"key":"R33-8-20210128","first-page":"651","article-title":"Bleomycin-induced scleroderma.","volume":"7","author":"Finch","year":"1980","journal-title":"J Rheumatol"},{"key":"R34-8-20210128","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E","article-title":"Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.","volume":"43","author":"Ioannou","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R35-8-20210128","first-page":"1601","article-title":"Exaggerated fibrosis in patients with systemic sclerosis (scleroderma) following radiation therapy.","volume":"20","author":"Abu-Shakra","year":"1993","journal-title":"J Rheumatol"},{"key":"R36-8-20210128","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.1989.tb01382.x","article-title":"Postirradiation morphoea.","volume":"120","author":"Colver","year":"1989","journal-title":"Br J Dermatol"},{"key":"R37-8-20210128","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1001\/jama.1991.03460240088033","article-title":"Exaggerated radiation-induced fibrosis in patients with systemic sclerosis.","volume":"265","author":"Varga","year":"1991","journal-title":"JAMA"},{"key":"R38-8-20210128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10552-009-9296-0","article-title":"Dose-response meta-analysis of silica and lung cancer.","volume":"20","author":"Lacasse","year":"2009","journal-title":"Cancer Causes Control"},{"key":"R39-8-20210128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00420-009-0505-7","article-title":"Occupational silica exposure as a risk factor for scleroderma: a meta-analysis.","volume":"83","author":"McCormic","year":"2010","journal-title":"Int Arch Occup Environ Health"},{"key":"R40-8-20210128","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/art.27549","article-title":"Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase IIII antibodies.","volume":"62","author":"Shah","year":"2010","journal-title":"Arthritis Rheumat"},{"key":"R41-8-20210128","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3899\/jrheum.101144","article-title":"Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.","volume":"38","author":"Airo","year":"2011","journal-title":"J Rheumatol"},{"key":"R42-8-20210128","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R43-8-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/art.38928","article-title":"Review: cancer-induced autoimmunity in the rheumatic diseases.","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R44-8-20210128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer.","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"R45-8-20210128","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.173.6.1433","article-title":"Induction of autoreactive B cells allows priming of autoreactive T cells.","volume":"173","author":"Lin","year":"1991","journal-title":"J Exp Med"},{"key":"R46-8-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R47-8-20210128","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"National Lung Screening Trial Research T. Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"Aberle","year":"2011","journal-title":"New Engl J Med"},{"key":"R48-8-20210128","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/M14-2426","article-title":"Cervical cancer screening in average-risk women: best practice advice from the Clinical Guidelines Committee of the American College of Physicians.","volume":"162","author":"Sawaya","year":"2015","journal-title":"Ann Intern Med"},{"key":"R49-8-20210128","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7326\/0003-4819-157-11-201212040-00008","article-title":"Upper endoscopy for gastroesophageal reflux disease: best practice advice from the Clinical Guidelines Committee of the American College of Physicians.","volume":"157","author":"Shaheen","year":"2012","journal-title":"Ann Intern Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:34:20Z","timestamp":1620948860000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201511000-00008"}},"subtitle":["a paraneoplastic disease with implications for malignancy screening"],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000222","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}